VitalStone Financial’s Gilead Sciences GILD Stock Holding History

VitalStone Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$24.4K	Buy	291 +3	+1%	+$229	0.02%	212
2024 Q2	$19.8K	Buy	288 +3	+1%	+$200	0.01%	226
2024 Q1	$21K	Buy	285 +3	+1%	+$231	0.02%	223
2023 Q4	$23K	Hold	282	–	–	0.02%	211
2023 Q3	$21K	Hold	282	–	–	0.02%	192
2023 Q2	$23K	Buy	+282	New	+$22.5K	0.01%	495
2023 Q1	–	Sell	-282	Closed	-$24K	–	421
2022 Q4	$24K	Buy	+282	New	+$22.3K	0.02%	245

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

VitalStone Financial's GILD Position: Q3 2024 in Review

VitalStone Financial increased its Gilead Sciences (GILD) stake by 1% in Q3 2024, buying an estimated $229 and bringing the position to 291 shares worth $24.4K. The position accounts for 0.02% of the portfolio, ranked #212.

VitalStone Financial first reported a position in GILD in Q4 2022 and has held it in 7 quarters since. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

VitalStone Financial held 291 shares of Gilead Sciences worth $24.4K as of Q3 2024.
VitalStone Financial bought 3 Gilead Sciences shares in Q3 2024, an estimated $229.
Gilead Sciences made up 0.02% of VitalStone Financial's portfolio in Q3 2024, its #212 holding.
VitalStone Financial first reported a position in Gilead Sciences in Q4 2022 and has held it in 7 quarters since.
1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.